Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer
Figure 5.Expression of EMT biomarkers. (A) SNAI1 and TWIST1 expression in CC patients and normal controls. (B) SNAI1, SNAI2, TWIST1, TWIST2, and ZEB2 expression in the low- and high-risk groups.